Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score

Barbui, T.; Ghirardi, A.; Carobbio, A.; Masciulli, A.; Carioli, G.; Rambaldi, A.; Finazzi, M.C.; Bellini, M.; Rumi, E.; Vanni, D.; Borsani, O.; Passamonti, F.; Mora, B.; Brociner, M.; Guglielmelli, P.; Paoli, C.; Alvarez-Larran, A.; Triguero, A.; Garrote, M.; Pettersson, H.; Andréasson, B.; Barosi, G.; Vannucchi, A.M.

doi:10.1038/s41408-022-00743-0

Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score / T. Barbui, A. Ghirardi, A. Carobbio, A. Masciulli, G. Carioli, A. Rambaldi, M.C. Finazzi, M. Bellini, E. Rumi, D. Vanni, O. Borsani, F. Passamonti, B. Mora, M. Brociner, P. Guglielmelli, C. Paoli, A. Alvarez-Larran, A. Triguero, M. Garrote, H. Pettersson, B. Andréasson, G. Barosi, A.M. Vannucchi. - In: BLOOD CANCER JOURNAL. - ISSN 2044-5385. - 12:11(2022 Nov 16), pp. 156.1-156.4. [10.1038/s41408-022-00743-0]